ENT, Service ORL, Chirurgie cervico-maxillo-faciale et audiophonologie, CHU de Poitiers, 2 rue de la Milétrie, 86000, Poitiers, France.
Radiotherapy, Centre François Baclesse/ARCHADE, Caen, France.
Ann Surg Oncol. 2019 Oct;26(11):3673-3680. doi: 10.1245/s10434-019-07589-0. Epub 2019 Jul 1.
The prognosis of advanced nodal (N3) squamous cell carcinoma of the head and neck (HNSCC) is poor. We investigated whether surgery or radiotherapy of early (T1-2) primary stage HSNCC is preferable to limit the overall morbidity after upfront neck dissection (uND) for N3 disease.
This retrospective multicentric Groupe d'Étude des Tumeurs de la Tête Et du Cou study included patients undergoing uND and surgery or radiotherapy of their primary. Prognostic factors were evaluated using propensity score matching to account for biases in performing surgery depending on primary site and stage.
Of 189 T1-2, N3 HNSCC patients, 70 (37.0%) underwent uND: 42 with surgery of their primary and 28 with radiotherapy only. Radiotherapy alone was more frequent in patients with hypopharyngeal primaries. All local (N = 3) and regional (N = 10) relapses (included 2 locoregional relapses) occurred within the first 2 years. There were 16 distant metastatic failures. Five-year locoregional relapse and survival incidences were 15.7% and 66.5% and were similar regardless of the treatment of the primary. The overall morbidity rate was 65.2% and was similar after weighting by the inverse propensity score (p = 0.148). The only prognostic factor for morbidity was the radicality of the uND. Prolonged parenteral feeding was not more frequent in patients only irradiated to their primary (p = 0.118). Prolonged tracheostomy was more frequent after surgery of the primary.
In patients with T1-2, N3 HNSCC undergoing uND, radiotherapy and surgery of the primary yield similar oncological outcomes. Morbidity was related to the extent of neck dissection.
晚期(N3)头颈部鳞状细胞癌(HNSCC)的预后较差。我们研究了对早期(T1-2)原发期 HNSCC 进行手术或放疗是否优于对 N3 疾病进行 upfront 颈部清扫术(uND)以限制整体发病率。
这项回顾性多中心 Groupe d'Étude des Tumeurs de la Tête Et du Cou 研究纳入了接受 uND 并对其原发灶进行手术或放疗的患者。使用倾向评分匹配来评估预后因素,以消除根据原发部位和分期进行手术的偏倚。
在 189 例 T1-2、N3 HNSCC 患者中,有 70 例(37.0%)接受了 uND:42 例接受了原发灶手术,28 例仅接受了放疗。下咽原发灶患者更常接受单纯放疗。所有局部(N=3)和区域(N=10)复发(包括 2 例局部区域复发)均发生在最初的 2 年内。有 16 例远处转移失败。5 年局部区域复发和生存发生率分别为 15.7%和 66.5%,且无论原发灶治疗如何,两者均相似。总发病率为 65.2%,通过逆倾向评分加权后相似(p=0.148)。发病率的唯一预后因素是 uND 的根治性。仅对原发灶进行放疗的患者中,长期肠外喂养并不常见(p=0.118)。原发灶手术后气管切开术更常见。
在接受 uND 的 T1-2、N3 HNSCC 患者中,放疗和手术治疗原发灶可获得相似的肿瘤学结果。发病率与颈部清扫术的范围有关。